What happens if Ryan Braun tests positive next year? Or in 2017?

25 Comments

One thing that is clear from the Ryan Braun suspension is that it was, in some form or another, the product of horse trading. A settlement of sorts given how both sides got something good out of this, all things considered.

But there is still an open question here: is this considered Braun’s first offense? Second? Is it off that paradigm altogether? Where in the heck are we now, and what in the heck happens if Braun dances with the PED devil at some point in the future?

The uncertainty stems from not just the punishment, but from the statements of Michael Weiner last week when he said that “just cause” punishment is not subject to the 50-100-life scale. That did not seem to jibe with the words of the JDA which seemed to include that scale in both testing positives and just cause situations, but that is what the man said. And, at least based on the number of games, that’s what Braun got.

It’s likely that other Biogenesis players will get similar deals (or punishments, depending on your point of view). Are they outside of the 50-100-life thing too? Or does this count as a first offense and the next one counts for 100 games? And what if the deal, say, in the case of A-Rod, is 103 games? Where do we go from there? How does the standard apply?

This is not a theoretical question. This set of circumstances could happen again. Or, like Manny Ramirez, we could have “retirements” that are rescinded followed by reductions in discipline. As time goes on the system is going to get messier and messier with precedent, as all systems do.

In light of that, I feel it’s important for Major League Baseball to clarify how the Biogenesis suspensions fit into the overall discipline regime of the JDA. For a system to work it has to have transparency. And, though it’s pretty clearly necessitated by the murkiness of the Biogenesis case, at the moment we’re lacking some transparency.

The Cubs will try to clinch the NL Central on Tuesday

Dylan Buell/Getty Images
Leave a comment

The Cubs soundly defeated the Cardinals on Monday night, 10-2, sending their magic number down to one. They will try to clinch the NL Central on Tuesday with another win against the Cardinals. Alternatively, if they lose, they can still clinch if the Brewers also lose on Tuesday.

The Cubs, of course, won the Central last year en route to winning their first World Series since 1908. It wasn’t nearly as easy this year as the club was below .500 entering June and was exactly at .500 entering July. A 16-8 July, 17-12 August, and 15-8 September have helped put the Cubs back in position to return to the postseason.

Not to be forgotten, the Cardinals were eliminated from NL Central contention with Monday’s loss. Now they have their sights set on the second NL Wild Card slot and currently trail the Rockies in that race.

The matchups for Tuesday’s action:

Carter Capps to undergo surgery for thoracic outlet syndrome

Kent Horner/Getty Images
Leave a comment

Dennis Lin of the San Diego Union Tribune reports that Padres pitcher Carter Capps will undergo surgery this offseason to address thoracic outlet syndrome, which doctors believe caused the right-hander’s blood clots. The Padres hope to have him ready by spring training next year.

Capps, 27, underwent Tommy John surgery last year and didn’t debut this season until August 7. He made 11 relief appearances, yielding nine runs on 12 hits and two walks with seven strikeouts in 12 1/3 innings. He went back on the DL on September 12 due to the blood clot issue.

The Padres acquired Capps from the Marlins last July in the Andrew Cashner trade which ended up having a lot of moving parts. Capps will enter his third and final year of arbitration eligibility this offseason. It’s quite possible the Padres choose to non-tender him.